Sinovac Biotech (NASDAQ:SVA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Sinovac Biotech (SVA) operate in?

Sinovac Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Sinovac Biotech Stock (NASDAQ: SVA) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	999.99

Recent News

CSPC Pharma Wins China's mRNA Vaccine Race, But Just Not Fast Enough

Key Takeaways: News of marketing approval for China’s first mRNA vaccine falls flat with investors, who worry the drug is being rushed to market before Phase 3 trials are complete As the pandemic abates, the market for the vaccine is shrinking rapidly By Ellie Si

The Bamboo Works

Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It

COVID-19 cases have spiked again in China, sparking fresh lockdown measures in the nation's capital. Jim Cramer has suggested that Chinese President Xi Jinping isn't telling the whole story.

Adam Eckert

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	999.99

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Sinovac Biotech (SVA) stock?

You can purchase shares of Sinovac Biotech (NASDAQ:SVA) through any online brokerage.

View our list of the best stock brokerages

Who are Sinovac Biotech (SVA) competitors?

Other companies in Sinovac Biotech’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Sinovac Biotech (SVA) stock?

There is no analysis for Sinovac Biotech to provide a consensus price target.

What is the current price for Sinovac Biotech (SVA)?

The stock price for Sinovac Biotech (NASDAQ: SVA) is $5.85 last updated December 24, 2018 at 9:29 AM EST.

Does Sinovac Biotech (SVA) pay a dividend?

There are no upcoming dividends for Sinovac Biotech.

When is Sinovac Biotech (NASDAQ:SVA) reporting earnings?

Sinovac Biotech’s H1 earnings are confirmed for Friday, August 16, 2024.

Is Sinovac Biotech (SVA) going to split?

There is no upcoming split for Sinovac Biotech.

What sector and industry does Sinovac Biotech (SVA) operate in?

Sinovac Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Sinovac Biotech

Sinovac Biotech (SVA) Forecast